Market Research Report
North America Implantable Cardiac Monitors Market Analysis (2017-2023)
|Published by||KBV Research||Product code||644793|
|Published||Content info||53 Pages
|North America Implantable Cardiac Monitors Market Analysis (2017-2023)|
|Published: May 17, 2018||Content info: 53 Pages||
The North America Implantable Cardiac Monitors Market would witness market growth of 6.8% CAGR during the forecast period (2017 - 2023).
The implantable cardiac monitor, which is also referred to as implantable loop recorder, is a tiny insertable device used in continuously monitoring hearth rhythms. The device is mostly placed in the left parasternal area of the chest. The device is also placed in some other parts of body, to minimize psychological impact of surgical scar in anterior chest region, without impairing the performance of the device.
Presently the market is witnessing moderate growth owing to the factors such as technological advancements in cardiac monitor devices such as miniaturization and easier implant procedures, growing demand for implantable cardiac monitors to continuously monitor heart to detect cardiac arrhythmias and atrial fibrillation. Additionally, growing cases of cardiovascular diseases, remote monitoring systems and growing use of implantable cardiac monitors to monitor epilepsy disorder add to the growth of the market.
Based on indication, the market report segments the market into Cardiac Arrhythmias, Atrial Fibrillation, and Epilepsy & Unexplained Falls. The end user segment covers Hospitals, Cardiac Center & Clinics, and Ambulatory Surgical Centers (ASCs). Based on countries, the Implantable Cardiac Monitors market segments the market into US, Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the North America Implantable Cardiac Monitors Market. Key companies profiled in the report include are Abiomed, Inc., Abbott Laboratories, Boston Scientific Corporation, Reliant Heart, Inc., Astellas Pharma inc., Thoratec Corporation St.(Jude Medical, LLC), Agilent Technologies, Inc., Berlin Heart GmbH, Schiller AG, and Jarvik Heart, Inc.